New Delhi: The expert panel of Drug Controller General of India (DCGI) on Thursday recommended that emergency use authorization be granted to the COVID-19 vaccine Corbevax for children in the...
Hong Kong: Two Chinese COVID-19 vaccine candidates, specifically developed to target the Omicron variant of coronavirus, have been approved for clinical trials as boosters in Hong Kong, Reuters reported. The...
Pune: Adar Poonawalla claimed on Wednesday that ‘Made in India’ COVID-19 vaccines have performed better than Pfizer and Moderna. “The Covid-19 vaccines which have been made in India are providing...
New York: At a time when a new variant of coronavirus (XE) has been detected in some countries including India, the World Health Organization (WHO) delivered a very comforting message...
New Delhi: The decision to make precaution (booster) doses for COVID-19 vaccine available for everyone above the age of 18 from April 10 was announced by the Union Health ministry...
Rajouri: Even after 15 months from the start of India’s inoculation drive against COVID-19, there is still opposition to vaccines. Members of a medical team which had travelled to Madhaar...
New Delhi: India started vaccinating children between the age of 12 and 14 years from March 16 with Biological E’s Corbevax. Soon, there will be a second option in the...
New Delhi: India started a precautionary third dose of the COVID-19 vaccine only in January. That, too, for frontline workers and people above the age of 60. Soon, the Central...
Paris: France will start offering a fourth COVID-19 vaccine dose for all those above 80 years of age from March 14. Israel was the first country to give its citizens...
New Delhi: The Drugs Controller General of India (DCGI) has granted emergency use authorization to the COVID-19 vaccine Covovax for 12-17 years age group, PTI reported on Wednesday quoting official...